InsidersTradesSigma
Track the 成大生物 stock price and the full directors' dealings record of the company, a listed equity based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 成大生物 has logged 2 insider filings. Market capitalisation: €8.2bn. The latest transaction was disclosed on 11 April 2023 (Purchase). Among the most active insiders: 崔建伟. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
成大生物是一家在上海证券交易所上市的医疗保健和制药领域的公司。它专注于生物和医药产品的研发。